Evidence map›Paper›PMID 42895604›Full record

ArticleNeurotoxicity research2026

Evaluation of Methylmercury-Induced Motor Dysfunction and Proteomic Analysis of Cerebrospinal Fluid in Common Marmosets (Callithrix jacchus).

Chisato Kataoka, Yingxi Li, Zoran Minic, Takashi Inoue, Terumi Yurimoto, Erika Sasaki, Yoshihiro Komohara, Komyo Eto, Naomichi Ogihara, Masaaki Nakamura and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Neurotoxicity research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Chisato KataokaDepartment of Environment and Public Health, National Institute for Minamata Disease, Minamata, Kumamoto, 867-0008, Japan.ORCID http://orcid.org/0000-0002-6901-0819
Yingxi LiFaculty of Science, University of Ottawa, Marie-Curie Private, Ottawa, ON, K1N 6N5, Canada.ORCID http://orcid.org/0000-0003-3325-7235
Zoran MinicFaculty of Science, University of Ottawa, Marie-Curie Private, Ottawa, ON, K1N 6N5, Canada.ORCID http://orcid.org/0000-0003-2520-0239
Takashi InoueDivision of Advanced Physiology, Central Institute for Experimental Medicine and Life Science, Kawasaki, 210-0821, Kanagawa, Japan.ORCID http://orcid.org/0000-0003-4691-7255
Terumi YurimotoDivision of Advanced Physiology, Central Institute for Experimental Medicine and Life Science, Kawasaki, 210-0821, Kanagawa, Japan.ORCID http://orcid.org/0000-0002-2783-8204
Erika SasakiDivision of Advanced Physiology, Central Institute for Experimental Medicine and Life Science, Kawasaki, 210-0821, Kanagawa, Japan.ORCID http://orcid.org/0000-0002-0415-5400
Yoshihiro KomoharaDepartment of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, 860-8556, Japan.ORCID http://orcid.org/0000-0001-9723-0846
Komyo EtoHealth and Nursing Facilities for the Aged, Jushindai, Shinwakai, Kumamoto, 865-0041, Tamana, Japan.
Naomichi OgiharaDepartment of Biological Sciences, Graduate School of Science, University of Tokyo, Bunkyo-ku, Tokyo, 113-0033, Japan.ORCID http://orcid.org/0000-0002-1697-9263
Masaaki NakamuraDepartment of Clinical Medicine, National Institute for Minamata Disease, Minamata, Kumamoto, 867-0008, Japan.ORCID http://orcid.org/0000-0002-4650-0460
Hing Man ChanFaculty of Science, University of Ottawa, Marie-Curie Private, Ottawa, ON, K1N 6N5, Canada.ORCID http://orcid.org/0000-0003-4351-7483
Megumi YamamotoDepartment of Environment and Public Health, National Institute for Minamata Disease, Minamata, Kumamoto, 867-0008, Japan. MEGUMI_YAMAMOTO@env.go.jp.ORCID http://orcid.org/0000-0002-4301-3827

Funding

Canada Research Chair Program CRC-2017-00179National Institute for Minamata Disease RS-25-06Natural Sciences and Engineering Research Council of Canada, Discovery Grant RGPIN-2019-06605
6 · The paper itself

Abstract

Methylmercury (MeHg) poisoning can lead to Minamata disease, often manifesting as motor dysfunction. We aimed to establish a quantitative evaluation method for MeHg exposure-associated motor dysfunction in the common marmoset (Callithrix jacchus). Three male marmosets were orally administered MeHg (1.5 mg Hg/kg/day) for 2 weeks, followed by a 2-week non-treatment period; three control marmosets received vehicle. Walking and spontaneous behavior were recorded weekly. After marking body segments, bounding gait videos were analyzed to assess locomotion speed, hip joint position, knee angle, dorsal neck-to-torso angle, and spontaneous behavior. In Hg-1 (MeHg-exposed marmoset with earliest symptom onset), locomotion speed and stride length decreased, while stride time increased. In Hg-2 (second marmoset to exhibit symptom onset), hip joint position and knee angle initially showed relatively normal fluctuations during bounding gait. However, their lower limits decreased following MeHg administration, and the dorsal neck-to-torso angle shifted from negative to positive. Spontaneous activity of Hg-1 and Hg-2 significantly decreased after MeHg administration. These results indicate that MeHg exposure-associated motor dysfunction in marmosets can be detected using our method, with particularly prominent lower-limb abnormalities. Furthermore, cerebrospinal fluid proteomic profiling revealed coordinated disruptions converging on three pathological axes-neuronal injury and neuroprotective responses, neuronal metabolic failure and cytosolic enzyme leakage, and impaired transport and homeostatic regulation-identifying nine proteins as candidate biomarkers. Proteomic alterations were consistent with the observed neuronal injury, neuroinflammation, metabolic dysfunction, and impaired homeostatic regulation in affected motor pathways. These findings establish the marmoset as a translational primate model for neurotoxicological assessments and biomarker discovery.

Indexed as

Methylmercury CompoundsAnimalsCallithrixMaleProteomicsMethylmercury CompoundsCerebrospinal fluidCommon marmosetMethylmercuryMotor dysfunctionNeurotoxicityProteomics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.